$KNSA SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Results of Operations and Financial Condition Date of Report (Date of earliest event reported): October 27, 2026
22 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On October 17, 2026, the Compensation Committee (the “Committee”) of the Board of Directors of Kiniksa Pharmaceuticals International, plc (the “Company”) appointed Ross Moat as President and Chief Operating Officer, effective immediately...
03 Sep 2026	Form 4: Ragosa Mark, CHIEF FINANCIAL OFFICER Received 9,104 shares by exercise or conversion · Gave up 4,404 shares to cover exercise price or tax ($349K) · Granted 7,800 Restricted Share Unit · 1 more
03 Sep 2026	Form 4: Patel Sanj K, Director Received 31,318 shares by exercise or conversion · Gave up 15,144 shares to cover exercise price or tax ($1.2M) · Granted 30,050 Restricted Share Unit · 1 more
03 Sep 2026	Form 4: Patel Sanj K, Director Received 31,318 shares by exercise or conversion · Gave up 15,144 shares to cover exercise price or tax ($1.2M) · Granted 30,050 Restricted Share Unit · 1 more
03 Sep 2026	Form 4: Paolini John F., CHIEF MEDICAL OFFICER Received 8,328 shares by exercise or conversion · Gave up 4,029 shares to cover exercise price or tax ($319K) · Granted 6,700 Restricted Share Unit · 1 more
03 Sep 2026	Form 4: Moat Ross, CHIEF OPERATING OFFICER Received 8,285 shares by exercise or conversion · Gave up 4,007 shares to cover exercise price or tax ($318K) · Granted 9,250 Restricted Share Unit · 1 more
03 Sep 2026	Form 4: Megna Michael R, CHIEF ACCOUNTING OFFICER Received 279 shares as a grant or award ($9.35K) · Received 11,496 shares by exercise or conversion · Gave up 5,531 shares to cover exercise price or tax ($438K) · 3 more
03 Sep 2026	144
21 Aug 2026	Form 4: Quart Barry D, Director Gave 2,600 shares as a gift
04 Aug 2026	Form 4: Levy Richard S, Director Received 403 shares by exercise or conversion · Granted 403 Restricted Share Units
31 Jul 2026	Form 4: Cole G Bradley, Director Sold 3,673 shares ($299K) · Gave 4,500 shares as a gift
29 Jul 2026	144
29 Jul 2026	144
29 Jul 2026	SCHEDULE 13G
28 Jul 2026	10-Q
28 Jul 2026	8-K: Results of Operations and Financial Condition
06 Jul 2026	Form 4: Malkani Dhiraj H, CHIEF STRATEGY OFFICER Granted 82,600 Share Option · Granted 14,000 Restricted Share Unit · Granted 4,307 Performance Share Option · 1 more
06 Jul 2026	Form 3: Malkani Dhiraj H, CHIEF STRATEGY OFFICER No securities owned
02 Jun 2026	Form 4: Quart Barry D, Director Received 2,799 shares by exercise or conversion · Granted 12,158 Share Option · Granted 2,026 Restricted Share Units

Comments